IRIS
RUGGERI, Rosaria Maddalena
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.263
NA - Nord America 14.086
AS - Asia 6.883
SA - Sud America 2.389
Continente sconosciuto - Info sul continente non disponibili 585
AF - Africa 250
OC - Oceania 18
Totale 43.474
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.614
RU - Federazione Russa 7.168
IT - Italia 6.241
SG - Singapore 2.763
BR - Brasile 2.017
CN - Cina 1.941
IE - Irlanda 1.538
SE - Svezia 1.324
HK - Hong Kong 736
DE - Germania 617
FR - Francia 568
VN - Vietnam 434
NL - Olanda 367
UA - Ucraina 346
FI - Finlandia 333
GB - Regno Unito 317
IN - India 249
CA - Canada 197
BD - Bangladesh 149
AR - Argentina 133
PL - Polonia 103
TR - Turchia 79
MX - Messico 78
IQ - Iraq 71
ZA - Sudafrica 71
EC - Ecuador 63
CO - Colombia 55
AT - Austria 51
CZ - Repubblica Ceca 51
JP - Giappone 51
ID - Indonesia 47
BE - Belgio 46
PK - Pakistan 45
MA - Marocco 43
UZ - Uzbekistan 42
ES - Italia 38
IL - Israele 37
VE - Venezuela 35
CR - Costa Rica 32
SA - Arabia Saudita 30
CH - Svizzera 27
CL - Cile 27
TN - Tunisia 25
CI - Costa d'Avorio 24
AE - Emirati Arabi Uniti 19
HN - Honduras 19
PE - Perù 19
TT - Trinidad e Tobago 19
IR - Iran 18
JM - Giamaica 18
MY - Malesia 18
PH - Filippine 18
KE - Kenya 17
LT - Lituania 17
PR - Porto Rico 17
AZ - Azerbaigian 16
DZ - Algeria 16
PY - Paraguay 16
SC - Seychelles 16
EG - Egitto 15
NI - Nicaragua 15
SV - El Salvador 15
CW - ???statistics.table.value.countryCode.CW??? 14
GT - Guatemala 14
KZ - Kazakistan 14
AL - Albania 13
DO - Repubblica Dominicana 13
GP - Guadalupe 13
AU - Australia 12
JO - Giordania 12
NP - Nepal 12
DK - Danimarca 11
UY - Uruguay 11
PT - Portogallo 10
RS - Serbia 10
BG - Bulgaria 9
BO - Bolivia 9
PS - Palestinian Territory 9
EU - Europa 8
LB - Libano 8
RO - Romania 8
GR - Grecia 7
KG - Kirghizistan 7
BY - Bielorussia 6
EE - Estonia 6
GE - Georgia 6
HU - Ungheria 6
LV - Lettonia 6
OM - Oman 6
PA - Panama 6
SN - Senegal 6
TH - Thailandia 6
XK - ???statistics.table.value.countryCode.XK??? 6
AM - Armenia 5
NO - Norvegia 5
SY - Repubblica araba siriana 5
BS - Bahamas 4
KR - Corea 4
LK - Sri Lanka 4
NG - Nigeria 4
Totale 42.846
Salva come PNG Salva come JPEG
Città #
Ashburn 2.040
Moscow 1.947
Dublin 1.522
Singapore 1.511
Dallas 1.261
Chandler 1.207
San Jose 843
Hong Kong 732
Nyköping 700
Beijing 693
Jacksonville 690
Milan 543
Council Bluffs 513
Rome 480
Messina 369
The Dalles 355
Los Angeles 285
Princeton 262
Lauterbourg 246
Dearborn 244
New York 243
Medford 226
Naples 214
Cambridge 204
Munich 187
Des Moines 186
Ann Arbor 163
São Paulo 151
Ho Chi Minh City 132
Turin 125
Buffalo 121
Santa Clara 119
Boardman 108
Bologna 101
Catania 97
Bremen 93
Bari 92
Palermo 89
Florence 80
Hanoi 79
Jinan 78
Tianjin 77
Wilmington 77
Warsaw 76
Redondo Beach 75
Turku 75
Guangzhou 71
Genoa 66
Lancaster 66
North Bergen 64
Pune 61
Helsinki 60
Dong Ket 58
Frankfurt am Main 58
Hyderabad 58
Nanjing 57
San Mateo 57
Houston 54
Woodbridge 54
Brooklyn 53
Orem 52
Phoenix 52
Rio de Janeiro 52
Shenyang 50
Brasília 49
Columbus 49
Atlanta 45
Montreal 45
Brussels 44
Denver 44
Tokyo 44
Belo Horizonte 42
Chicago 42
Johannesburg 41
Seattle 41
San Francisco 40
Brescia 39
London 37
Vienna 36
Zhengzhou 36
Tashkent 35
Porto Alegre 33
Chennai 31
Parma 31
Shenzhen 31
Modena 30
Shanghai 30
Trieste 30
Hebei 29
Toronto 29
Ningbo 28
Verona 28
Cagliari 27
Haikou 27
Nuremberg 27
Brno 26
San José 26
Hangzhou 25
Abidjan 24
Baghdad 24
Totale 21.999
Salva come PNG Salva come JPEG
Nome #
LA LOCALIZZAZIONE ISTMICA DEL NODULO TIROIDEO MALIGNO RAPPRESENTA UN FATTORE ADDIZIONALE DI RISCHIO PER METASTASI IN PAZIENTI AFFETTI DA CARCINOMA DIFFERENZIATO DELLA TIROIDE (CDT) A BASSO RISCHIO 4.757
I LIVELLI SIERICI DI INTERLEUCHINA 23 (IL-23) SONO AUMENTATI NEI PAZIENTI CON TIROIDITE DI HASHIMOTO (TH) DI NUOVA DIAGNOSI RISPETTO AI CONTROLLI SANI 755
EMIAGENESIA TIROIDEA, MORBO DI BASEDOW-GRAVES E CARCINOMA DIFFERENZIATO DELLA TIROIDE: UN’ASSOCIAZIONE MOLTO RARA. 335
IL GRADO DI COINVOLGIMENTO CUTANEO, VALUTATO COME SKIN SCORE SECONDO RODNAN, NEI PAZIENTI CON SCLEROSI SISTEMICA (SS) CORRELA CON I LIVELLI SIERICI DI TSH 328
99mTc-Methoxy-Isobutyl-Isonitrile Scintigraphy Is a Useful Tool for Assessing the Risk of Malignancy in Thyroid Nodules with Indeterminate Fine-Needle Cytology 290
131I RADIOIODINE THERAPY (RIT) OF HYPERTYROIDISM DUE TO GRAVES’ DISEASE (GD) OR UNI-MULTINODULAR TOXIC GOITER (NTG): OUR EXPERIENCE 267
131I Radioiodine therapy (RIT) of hyperthyroidism due to Graves' disease (GD) or uni-multinodular toxic goiter (NTG): our experience 259
Effects of GH replacement therapy on thyroid volume and nodule development in GH deficient adults: a retrospective cohort study 237
Expression of P53 and isoforms in bening and malignant lesions of the head and neck 221
Cardiovascular events in acromegaly: distinct role of Agatston and Framingham score in the 5-year prediction. 218
ACCIDENTAL DISCOVERY OF LUNG METATSTASES FROM DIFFERENTIATED THYROID CANCER BY TC-99M PERTECHNETATE SCAN IN A PATIENT WITH SECONDARY HYPERPARATHYROIDISM 215
I livelli sierici di interleuchina 22 (IL-22) sono aumentati nella tiroidite di Hashimoto rispetto alle tireopatie non autoimmuni ed ai controlli sani. 215
Abnormal 99mTc-MIBI Uptakein left lung mimicking a neoplastic lesion in a young woman with nodular goiter. A rare pitfall of 99mTc-MIBI 212
Orticaria e Tireopatie autoimmuni. 210
AN UNUSUAL CASE OF MARINE-LENHART SYNDROME. 209
Abnormal radioiodine uptake on post-therapy whole body scan and sodium/iodine symporter expression in a dermoid cyst of the ovary: report of a case and review of the literature 208
Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions 205
An analytical model for improving absorbed dose calculation accuracy in non spherical autonomous functioning thyroid nodule 205
Association of parathyroid carcinoma and thyroid disorders: A clinical review 205
Cell proliferation parameters and apoptosis indices in pituitary macroadenomas 204
Immunoreactions for P53 isoforms are associated with ultrastructural proliferative profiles in benign thyroid nodules 204
BRAFV600Emutation is associated with increased prevalence of contralateral lymph-node metastases in low and low-to-intermediate risk papillary thyroid cancer 200
Association of autonously functioning ("hot") thyroid nodules with Hashimotos' thyroiditis (HT). 199
99mTc-Methoxy-Isobutil-Isonitrile (MIBI) scintigraphy is an useful and cost-effective tool for assessing the risk of malignancy in thyroid nodules with indeterminate fine needle cytology (FNAC) 199
Allelic loss at 7q21 is a frequent and early event in thyroid follicular tumors. 196
Hyaluronan oligosaccharides induce inflammatory response in human thyrocytes cultures by affecting Toll-like receptors 196
ACCUMULO DI TECNEZIO IN METASTASI POLMONARI DA CARCINOMA DIFFERENZIATO TIROIDEO (CDT): UNA RARA EVENIENZA 195
Central nervous system vasculitis after starting methimazole in a woman with Graves' disease 195
Hyperthyroidism treatment with calculated activity of 131-Radioiodine: our experience 192
Un caso di orticaria cronica idiopatica (OCI) associata a morbo di Basedow (MB): tipizzazione HLA. 192
Abnormal radioiodine uptake in an abdominal dermoid cyst in a patient affected by differentiated thyroid cancer 192
Co-expression of interleukin-6 (IL-6) and interleukin-6 receptor (IL-6R) in thyroid nodules is associated with co-expression of CD30 ligand/CD30 receptor 191
CD30 and CD30 ligand (CD30L) expression in decidual samples of spontaneous abortions. 191
Accidental discovery of lung metastases from differentiated thyroid cancer by 99mTc sodium pertechnetate scan in a patient with secondary hyperparathyroidism 191
AUMENTATO STRESS OSSIDATIVO NELLA TIROIDITE DI HASHIMOTO (TH) CON EUTIROIDISMO 190
Early preablation rhTSH-stimulated thyroglobulin predicts outcome of differentiated thyroid cancer (DTC) patients 190
Is malignant nodule topography an additional risk factor for metastatic disease in low-risk differentiated thyroid cancer? 189
Analisi immunoistochimica dei "pathways" del sistema HGF/c-met in noduli tiroidei benigni e maligni. 188
Analisi immunoistochimica dell'espressione dlel'epidermal growth factor receptor (EGFR) e di HER2 nel carcinoma midollare della tiroide (MCT). 187
Alemtuzumab-induced thyroid events in multiple sclerosis: a systematic review and meta-analysis 187
HER2 analysis in sporadic thyroid cancer of follicular cell origin 183
Parathyroid carcinoma presenting as normocalcemic hyperparathyroidism 183
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG) 182
Radiometabolic therapy with 131I for the ablation of the thyroid remnant in patients affected by differentiated thyroid cancer: comparison between four different activities 182
I livelli sierici di Interleuchina 37 (IL-37) sono aumentati nella Tiroidite di Hashimoto (TH) e correlano con i marcatori di stress ossidativo 182
Increased serum interleukin-22 levels in patients with PRL-secreting and non-functioning pituitary macroadenomas. 181
Hyaluronan oligosaccharides modulate inflammatory response, NIS and thyreoglobulin expression in human thyrocytes 180
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low risk differentiated thyroid cancer? 179
Oxidative stress as a key feature of autoimmune thyroiditis: an update 179
Dioxin-like pentachlorobiphenyls promote extra-cellular matrix remodeling by increasing the expression of endothelial cell-specific molecule 1 and metalloproteinases, and induce epigenetic modifications in thyrocytes 178
Braf V600E and 99m-TC MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy. 178
Combined BRAFV600Eanalysis and99mTc-MIBI scintigraphy can be a useful diagnostic tool in differentiated thyroid cancer patients with incomplete bio-chemical response to first radioiodine therapy (RAIT): a pilot investigation 178
Aplotipi del microsatellite D7S6440, localizzato nell'introne 9 del gene HIPK2, come marcatori molecolari della tiroidite di Hashimoto 177
Oxidative Stress and Advanced Glycation End Products in Hashimoto's Thyroiditis 177
Isthmus topography is a risk factor for persistent disease in patients with differentiated thyroid cancer 177
Autoimmune comorbidities in Hashimoto's thyroiditis: different patterns of association in adulthood and childhood/adolescence 176
Clinical usefulness of 99mTc-MIBI scintigraphy in the postsurgical evaluation of patients with differentiated thyroid cancer 175
Adverse childhood experiences and negative emotional responses : risk factors for thyroid autoimmune diseases? 175
Thyroid remnant ablation in differentiated thyroid cancer: searching for the most effective radioiodine activity and stimulation strategy ina real life scenario 174
Association of autonomously functioning thyroid nodules (AFTNs) with Hashimoto's thyroiditis (HT) 173
Follicular variant of papillary thyroid carcinoma presenting as toxic nodule in an adolescent: coexistent polymorphism of the TSHR and Gsα genes 173
Differentiating malignant from benign thyroid nodules with indeterminate cytology by 99mTc-MIBI scan: A new quantitative method for improving diagnostic accuracy 173
Coexistence of diffuse large B-cell lymphoma and papillary thyroid carcinoma in a patient affected by hashimoto's thyroiditis 173
Primary Neuroendocrine Neoplasms of the Breast: Still Open Issues 172
Malattie della Tiroide-Note di anatomia e fisiologia 171
Increased frequency of the rs2066853 variant of aryl hydrocarbon receptor gene in patients with acromegaly 171
Could AGE/RAGE-related oxidative homeostasis dysregulation enhance susceptibility to pathogenesis of cardio-metabolic complications in childhood obesity? 171
ATYPICAL PRESENTATION OF PARATHYROID CARCINOMA (PC): REPORT OF TWO CASES 170
HGF/c-met system targeting PI3K/AKT and STAT3/phosphorylated-STAT3 pathways in pituitary adenomas: an immunohistochemical characterization in view of targeted therapies. 168
Predictive markers of recurrence in radically resected pituitary macroadenomas 166
ASSOCIATION OF PRIMARY HYPERPARATHYROIDISM (P-HYPERPTH) WITH NODULAR TOXIC GOITER (NTG): A PROSPECTIVE STUDY AT AN OUTPATIENT OSTEOPOROSIS SERVICE 166
Hyperthyroidism treatment with calculated activity of 131–radioiodine 166
FOLLICULAR VARIANT OF PAPILLARY THYROID CARCINOMA PRESENTING AS A TOXIC NODULE IN AN ADOLESCENT GIRL 165
An uncommon case of Marine-Lenhart syndrome 165
Iodine-131 treatment of hyperthyroidism: our experience 164
Correlation of cardio-metabolic parameters with vitamin D status in healthy premenopausal women 164
Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspective 164
Association of autonomously functioning thyroid nodules with Hashimoto’s thyroiditis: study on a large series of patients 163
Expressions of Δ 133 isoforms of P53 in multinodular thyroids: the immunoreactions in benign lesions are correlating with subcellular phenotypes of electron microscopy 163
La paratiroidectomia radioguidata 162
Expression of CD30 ligand and CD30 receptor in normal thyroid and benign and malignant thyroid nodules 161
Association of primary hyperparathyroidism (p-hyperPTH) with nodular toxic goiter (NTG): a prospective study at an outpatient osteoporosis service 161
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 161
Cell-specific loss of heterozygosity (LOH) on chromosome 7q21 in thyroid tumors: analysis on 267 laser capture microdissected thyroid lesions 160
Can the position of malignant thyroid nodule be considered as additional risk factor for recurrent and/or metastatic disease in patients affected by low-risk differentiated thyroid cancer? 160
Hyaluronan oligosaccharides down-regulate NIS and thyroglobulin expression in human thyrocytes 160
Supra-Acetabular Brown Tumor due to Primary Hyperparathyroidism Associated with Chronic Renal Failure 159
I livelli sierici del recettore solubile per i prodotti avanzati di glicazione sono ridotti in pazienti pediatrici con tiroidite di Hashimoto 159
Associazione tra noduli tiroidei iperfunzionanti (noduli "caldi") e tiroidite di Hashimoto 158
Endocrine and metabolic adverse effects of immune checkpoint inhibitors: an overview (what endocrinologists should know) 158
Comparing radioiodine abdominal absorbed dose in differentiated thyroid cancer patients undergone thyroid remnant ablation in either levo-thyroxine withdrawal or after rhtsh stimulation 157
BRAFV600E and 99mTc-MIBI scintigraphy are usefull diagnostic tools in identifying metastatic differentiated thyroid cancer patients refractory to radioiodine therapy 156
Comment on “Prevalence of undifferentiated inflammatory arthropathy in patients with Hashimoto's thyroiditis in an endocrinology clinic” by Luis M. Valderrama-Hinds and co-workers. Int J Rheum Dis 2019; 22: 1985-1989 156
BRAF and RAS mutations in differentiated thyroid cancer of patients with low-risk to intermediate-risk treated with radioiodine therapy 156
ATYPICAL PRESENTATION OF PARATHYROID CARCINOMA (PC): REPORT OF TWO CASES 155
Hepatocyte growth factor/C-met axis in thyroid cancer: From diagnostic biomarker to therapeutic target 155
Association of autonomously functioning ("hot") thyroid nodules with Hashimoto's thyroiditis 154
Usefulness of L-carnitine, a naturally occurring peripheral antagonist of thyroid hormone action, in iatrogenic hyperthyroidism: A randomized. double-blind, placebo-controlled clinical trial 153
Effetto proinfiammatorio degli oligosaccaridi dell'acido ialuronico in tireociti e fibroblasti umani: ruolo dei recettori tool-like di tipo 2(TLR-2) e 4(TLR-4) 153
Influence of Dietary Habits on Oxidative Stress Markers in Hashimoto's Thyroiditis 152
Totale 23.682
Salva come PNG Salva come JPEG
Categoria #
all - tutte 134.663
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 134.663
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.473 0 0 0 0 77 29 101 95 38 299 247 587
2022/20234.804 362 431 232 340 384 534 78 273 1.863 45 178 84
2023/20242.547 111 189 168 216 179 425 121 182 102 271 199 384
2024/20258.349 298 240 372 619 586 404 381 1.521 1.569 587 685 1.087
2025/202617.987 999 1.265 1.273 1.104 1.481 3.585 2.111 2.161 2.356 881 380 391
2026/20273.480 405 823 817 1.173 262 0 0 0 0 0 0 0
Totale 43.474